Articlenpj women's health2026
The Callascope: A portable, user-friendly, speculum-free device for diagnostic imaging of cervical cancer precursor lesions.
Article in npj women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cervical cancer remains a leading cause of preventable mortality in low- and middle-income countries, where visual inspection with acetic acid (VIA) is often used for screening. VIA's reliability is limited by the lack of magnification, absence of imaging for review, and high inter-operator variability. We developed the Callascope, a portable colposcope designed to address these limitations by integrating high-resolution imaging and acetic acid application in a single device. The Callascope can be used with or without a speculum and incorporates an asymmetrical tip for cervix positioning, an integrated camera with illumination, and a built-in atomizer for uniform contrast application. Bench testing confirmed image quality and contrast application were comparable to a standard colposcope. In clinical studies, the Callascope enabled consistent cervical visualization, effective acetowhitening, and reliable image interpretation while improving patient comfort. By addressing VIA's limitations, it has the potential to expand screening access and support global cervical cancer elimination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.